Henrik Hasseldam Selected Research

talipexole

1/2014

Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrik Hasseldam Research Topics

Disease

6	Stroke (Strokes) 04/2019 - 10/2006
3	Brain Ischemia (Cerebral Ischemia) 01/2019 - 10/2006
3	Ischemia 01/2019 - 05/2013
3	Infarction (Infarctions) 01/2019 - 10/2006
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 10/2006
3	Multiple Sclerosis 01/2018 - 01/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 01/2010
2	Necrosis 11/2014 - 03/2005
2	Hypothermia 01/2014 - 10/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013 - 03/2005
2	Demyelinating Diseases (Demyelinating Disease) 09/2011 - 01/2010
1	Infections 07/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Hypoxia (Hypoxemia) 05/2015
1	Parkinson Disease (Parkinson's Disease) 01/2014
1	Atrophy 09/2011
1	Inflammation (Inflammations) 03/2005

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 04/2019 - 10/2006
2	Pharmaceutical PreparationsIBA 11/2014 - 01/2014
2	CalpainIBA 11/2014 - 09/2011
2	Therapeutic UsesIBA 01/2013 - 10/2006
2	CannabinoidsIBA 09/2011 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 03/2005
1	C-Reactive ProteinIBA 07/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2019
1	Interleukin-18 (Interleukin 18)IBA 04/2019
1	GTP Phosphohydrolases (GTPases)IBA 04/2019
1	Actin Depolymerizing Factors (Cofilins)IBA 04/2019
1	Protein Subunits (Protein Subunit)IBA 04/2019
1	InterferonsIBA 04/2019
1	Myosin-Light-Chain PhosphataseIBA 04/2019
1	Myosin-Light-Chain KinaseIBA 04/2019
1	Protein Kinases (Protein Kinase)IBA 04/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Tat-NR2B9cIBA 01/2019
1	UCCB01-144IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	ChemokinesIBA 01/2016
1	CCAAT-Enhancer-Binding ProteinsIBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	GlucocorticoidsIBA 11/2014
1	Caspase 3 (Caspase-3)IBA 11/2014
1	Serotonin ReceptorsIBA 11/2014
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 11/2014
1	ipsapironeIBA 11/2014
1	PiperazineIBA 11/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2014
1	SpectrinIBA 11/2014
1	talipexoleIBA 01/2014
1	Dopamine (Intropin)FDA LinkGeneric 01/2014
1	pimonidazoleIBA 05/2013
1	CaspasesIBA 09/2011
1	Interleukin-12 (IL 12)IBA 01/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2010
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 10/2006
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2006
1	EndocannabinoidsIBA 10/2006
1	Cannabinoid Receptor AgonistsIBA 10/2006
1	Neuroprotective AgentsIBA 10/2006
1	Phosphotransferases (Kinase)IBA 03/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2005
1	3,9-bis((ethylthio)methyl)-K-252aIBA 03/2005
1	Interleukin-6 (Interleukin 6)IBA 03/2005

Therapy/Procedure

4	Induced Hypothermia 05/2015 - 10/2006
1	Cardiac Surgical Procedures 01/2014
1	Drug Therapy (Chemotherapy) 01/2013
1	Immunomodulation 01/2010